British Patient Capital

Quick Facts

AUM

$1.5B

AUM Category

$1B-$5B

Headquarters

London, UK

Founded

2018

Team Size

50-100

About British Patient Capital

British Patient Capital is a prominent private equity firm that operates under the auspices of the British Business Bank, focusing on the growth stage investment sector. Established to drive innovation and support the development of high-potential UK businesses, the firm adheres to a long-term investment philosophy that emphasizes patient capital. This approach enables them to provide the necessary time and resources for portfolio companies to scale and achieve their full potential, distinguishing them from traditional private equity firms that may prioritize shorter-term returns. The firm primarily targets sectors that are poised for growth and transformation, including technology, healthcare, and sustainable industries. British Patient Capital seeks to invest in companies that demonstrate strong market positions and the potential for significant expansion. Their investment strategy often includes backing firms that are developing cutting-edge technologies or disruptive business models, allowing them to capitalize on emerging trends and shifts in consumer behavior. The firm typically engages in investments ranging from £1 million to £10 million, aiming to support early to mid-stage companies with a clear path to profitability and sustainable growth. What sets British Patient Capital apart in the private equity landscape is its backing by the UK government and its commitment to fostering innovation across the economy. This unique positioning enables them to leverage public sector insights and resources, enhancing their ability to identify and cultivate high-potential businesses. Moreover, their focus on patient capital means they are more willing to provide capital in situations where longer-term investment horizons are essential for success. This approach can be particularly appealing to interim executives and operating partners who are tasked with steering companies through transitional phases or strategic pivots. For interim executives considering collaboration with British Patient Capital, it is important to understand the firm's emphasis on long-term value creation and its supportive investment style. Partnering with them may involve navigating the complexities of scaling operations while aligning with their strategic vision. Additionally, executives should be prepared to engage in a collaborative dialogue about growth strategies, as the firm values partnerships that enhance the operational capabilities of its portfolio companies. This alignment can provide a conducive environment for driving transformative change within targeted businesses.

Investment Focus

Sectors: Technology, Healthcare, Consumer

Investment Stages: Venture, Growth

Portfolio Focus: B2B, B2C, HealthTech

Regional Offices

• London

Connect with British Patient Capital

• Website